Skip to Content
Merck
CN

Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam.

European journal of clinical pharmacology (2007-11-09)
Mária Tóth, Sándor Drabant, Bálint Varga, Gyula Végso, Anna Cseh, Imre Szentpéteri, Imre Klebovich
MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Tofisopam, ≥98% (HPLC), solid